-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
January 01, 2013 - treatments. … Treatment in Adolescents
Two trials evaluated therapies in children and
adolescents; one trial of … A
systematic review of treatments for refractory
depression in older people. … treatments. … Treatment in Adolescents
Two trials evaluated therapies in children
and adolescents; one trial of
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-5.pdf
February 01, 2018 - .
► This leaves patients and clinicians largely unable to directly compare across
treatments
• Network … • Inconsistency may be due to several factors, including: differences in
patients, treatments, settings … Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many … • Cautiously use inference based on the rankings and probabilities of treatments being
most effective … Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
October 01, 2006 - summarizes the evidence evaluating the
effect and safety of angioplasty with stent placements
and medical therapies … regimens, and indirect comparisons
between angioplasty with stent, surgical interventions,
various medical therapies … Only four cohort studies evaluated ACE
inhibitors or “triple therapy,” treatment with three
classes of … Summary of Comparative Data in Treatments of Renal Artery Stenosis
Key Questions Strength of evidence … stent) or surgical revascularization to
various medical treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - Tumor type, treatment
regimen, and history of prior cancer
therapy influence the risk and severity of … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … How do alternative thresholds for initiating
treatment or alternative criteria for discontinuing
therapy … Thresholds for initiating treatment or
criteria for discontinuing therapy
Three unblinded randomized … No trials compared criteria for discontinuing
therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
May 29, 2025 - $$
Click$here$to$enter$text.$
(
Persistence$with$drug$therapy/treatment$adherence$$
SRC(Literature … $Aliskiren$and$ARB$treatment$did$
not$differ$in$rates$of$BP$control$or$therapeutic$
response.$
$ … $Aliskiren$and$ARB$treatment$did$not$differ$in$rates$of$BP$control$or$therapeutic$
response. … $Fixed"dose$
combination$therapy$is$currently$recommended$for$the$treatment$of$hypertension$due$to$the … $The$incidence$
of$adverse$events$was$similar$across$treatments$(32.9"36.0%),$although$ramipril$treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
December 17, 2013 - have
the potential to be widely used in the U.S. in the next 5 years or so for the
evaluation of treatments … What types of imaging technologies are you developing for the assessment of
treatments for metastatic … What do you believe will be the role of biomarkers for the assessment of
treatments for metastatic breast … ,
Drug Therapy, Prevention & Control, Radiotherapy, Surgery,
Therapy]
101054
3 exp Neoplasm Metastasis … Particle beam radiation therapies for cancer: Agency for Healthcare
Research and Quality; 2009.
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … MSC therapy
has the potential to be a first-line OA-treatment option that could regenerate articular … As with MSC therapy, preparation
ES-4
protocols and injection frequency vary among treatment … improvement provided by PRP for knee OA was 9 months.
27
Autologous PRP is not considered a drug or a therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
January 01, 2013 - Confounding by indication leads to higher propensity for treatment or more intensive treatment in those … Multiple outcomes can be assessed from given treatments. … for covariates that may be affected by prior treatments. … The causal interpretation changes from the effect of treatment versus no treatment on the outcome to … A meta-analysis of the association between adherence to drug therapy and mortality.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_executive.pdf
April 01, 2011 - Individual goals for treatment vary
for different children and may include
combinations of therapies.4 … individual providing the therapy? … treatment or across treatments? … outcomes assessment outside the
therapeutic environment, with positive results observed. … The effect of
therapeutic horseback riding on social functioning in children
with autism.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
December 01, 2017 - for fibroids 1 30 0.23
GnRH = gonadotropin-releasing hormone; HRT = hormone replacement therapy; IUD … Four studies evaluated therapies in
postmenopausal women. … Among medical therapies, GnRH agonists, mifepristone,
and ulipristal reduced fibroid size and improved … trajectories in which all initial treatments can be
followed by all possible combinations of next treatments … No data is available
to indicate whether use of therapeutics short of surgery
might forestall or prevent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
September 01, 2012 - o Does the use of the SFLC assay influence the type of treatment (e.g., radiation
therapy)? … of treatment or use of
adjunctive therapy or stem-cell transplantation) in patients with PCDs? … o Does the use of the SFLC assay influence the type of treatment (e.g., radiation
therapy)? … of treatment or
use of adjunctive therapy or stem-cell transplantation) in patients with PCDs? … Does the use of the SFLC assay influence the type of treatment (e.g.,
radiation therapy)?”
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - Nonpharmacologic Therapies
Four small, short-term studies assessed nonpharmacologic
therapies in adults … One low-quality RCT evaluated
near-infrared light therapy compared with sham treatment. … However, adverse
effects of pharmacologic therapies and long-term treatment
withdrawals due to adverse … • Randomized trials of nonpharmacologic treatments
including herbal therapy, mind-body medicine, and … characteristics, such as disease
duration and previous therapy, affect
treatment outcomes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - Effectiveness
Reviews, the program supports
systematic appraisals of existing
scientific evidence regarding
treatments … frequency of
administration, and gestational age at initiation or
discontinuation of progestogen therapy … Treatment of women with preterm labor was associated
with prolonged time from treatment to birth in … Modifiers of Outcomes by Cointerventions
Ten studies with distinct populations reported using
tocolytic treatments … Progesterone for maintenance tocolytic therapy
after threatened preterm labour: a randomised controlled
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-pharmacologic-treatment_research-protocol.pdf
December 27, 2016 - • KQ1a: No treatment (placebo or control) OR pharmacologic therapy which
includes controller therapy … KQ2a-b: ICS+LAMA controller therapy
KQ2c: ICS+LABA+LAMA controller therapy
Therapies considered … listed in the PICOTS
Comparator KQ1a: No treatment OR pharmacologic
therapy OR non-pharmacologic … Therapies are further defined according to
PICOTS above. … as
defined in PICOTS
KQ2c: ICS+LABA controller therapy
Therapies considered an ICS, LABA or
LAMA
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
December 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … efficacy for suicidal
ideation and as an adjunct treatment to behavior and brain-stimulation therapies … Double-blind,
placebo-controlled trial of ketamine therapy in
treatment-resistant depression (TRD … Proof-of-
concept trial of ketamine therapy in treatment-
resistant depression (RAPID). … Therapeutic options in
treatment-resistant depression. Ann Med. 2011
Nov;43(7):512-30.
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
December 29, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … Treatments such as nonsteroidal anti-inflammatory
drugs (NSAIDs) are used for first-line therapy to … Patients with AS who did not respond to prior treatment with TNF
therapies showed significant improvement … with
existing therapies. … Clinical Pathway at Point of This Intervention
AS treatment focuses on physical therapy and exercise
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-treatment_research-protocol.pdf
November 08, 2011 - , and hyperbaric oxygen
therapy. … Interventions
Various treatment strategies for pressure ulcers including but not limited to therapies … (e.g., physical therapy) … treatments in combination with a single treatment). … of the therapeutic intervention.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-202-bronchial-thermoplasty-asthma.pdf
December 01, 2017 - are
managed with multiple medications that
may include inhaled, orally administered,
and biologic therapeutics … BT is usually given as three treatments
3 weeks apart. … period than standard
treatment. … BT was associated with fewer
ED visits than sham treatment during the post-treatment
period (moderate … months after
therapy and can last for at least 5 years, after which the
effect is unknown
e
Reference
-
effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
October 01, 2007 - evaluating
a new diabetes drug, there were no demonstrable differences in
outcomes relative to existing therapies … Diego, CA), was approved by the Food and Drug
Administration in April 2005 for use as an adjunctive therapy … In prelicensing trials, up to 20% of
patients discontinued therapy due to nausea; however, the
efficacy … Statistical Framework
We developed methodology to compare a new medi-
cation relative to established therapies … These
models do not allow us to predict what outcomes would be for
patients who start and stop therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
October 01, 2011 - ,2835 and
New Forest Parenting Program3639 share common
therapeutic components and are documented … Social support and treatment
outcome in behavioral family therapy for child conduct
problems. … Parent
child interaction therapy: a comparison of standard and
abbreviated treatments for oppositional … Parentchild interaction therapy with behavior problem
children: maintenance of treatment effects in … Parentchild
interaction therapy: a psychosocial model for the
treatment of young children with conduct